BC
WINT

Broadfin Capital’s Windtree Therapeutics Inc WINT Stock Holding History

Broadfin Capital’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-777,797
Closed -$887K – 66
2017
Q1 		$887K Hold
777,797
– – 0.11% 52
2016
Q4 		$972K Hold
777,797
– – 0.11% 61
2016
Q3 		$1.99M Hold
777,797
– – 0.18% 65
2016
Q2 		$1.5M Hold
777,797
– – 0.15% 63
2016
Q1 		$1.3M Sell
777,797
-1
-0% -$2 0.13% 67
2015
Q4 		$2.33M Buy
777,798
+100,000
+15% +$410K 0.14% 80
2015
Q3 		$2.85M Buy
677,798
+119,048
+21% +$788K 0.16% 77
2015
Q2 		$5.32M Sell
558,750
-17,857
-3% -$251K 0.29% 73
2015
Q1 		$9.61M Buy
576,607
+464
+0.1% +$9.13K 0.75% 37
2014
Q4 		$9.36M Hold
576,143
– – 0.81% 33
2014
Q3 		$14.8M Hold
576,143
– – 1.56% 19
2014
Q2 		$14.4M Hold
576,143
– – 1.4% 23
2014
Q1 		$17.3M Hold
576,143
– – 1.68% 18
2013
Q4 		$18.1M Buy
576,143
+421,429
+272% +$13.2M 2.39% 16
2013
Q3 		$4.25M Buy
154,714
+35,714
+30% +$866K 0.75% 35
2013
Q2 		$2.53M Buy
+119,000
New +$2.93M 0.5% 40

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Broadfin Capital's WINT Position: Q2 2017 in Review

Broadfin Capital sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 777,797 shares — an estimated $887K sold.

Broadfin Capital first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $18.1M in Q4 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Broadfin Capital reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Broadfin Capital sold 777,797 Windtree Therapeutics Inc shares in Q2 2017, an estimated $887K.
  • Broadfin Capital first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Broadfin Capital's Windtree Therapeutics Inc position peaked at $18.1M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Broadfin Capital's 13F filing for Q2 2017, filed 14 Aug 2017.